Article Versions Notes

Huang K-J, Chang W-C, Chen C-H, Lin W-C, Pan WW-L, Hsieh H-I, Hsieh Y-H, Wei L-H, Sheu B-C. Urine Protein to Creatinine Ratio for the Assessment of Bevacizumab-Associated Proteinuria in Patients with Gynecologic Cancers: A Diagnostic and Quality Improvement Study. Diagnostics. 2024; 14(17):1852. https://doi.org/10.3390/diagnostics14171852

Huang, Kuan-Ju, Wen-Chun Chang, Chi-Hau Chen, Wei-Chen Lin, William Wei-Lin Pan, Hao-I. Hsieh, Yu-Hsiung Hsieh, Lin-Hung Wei, and Bor-Ching Sheu. 2024. "Urine Protein to Creatinine Ratio for the Assessment of Bevacizumab-Associated Proteinuria in Patients with Gynecologic Cancers: A Diagnostic and Quality Improvement Study" Diagnostics 14, no. 17: 1852. https://doi.org/10.3390/diagnostics14171852

Huang, K.-J., Chang, W.-C., Chen, C.-H., Lin, W.-C., Pan, W. W.-L., Hsieh, H.-I., Hsieh, Y.-H., Wei, L.-H., & Sheu, B.-C. (2024). Urine Protein to Creatinine Ratio for the Assessment of Bevacizumab-Associated Proteinuria in Patients with Gynecologic Cancers: A Diagnostic and Quality Improvement Study. Diagnostics, 14(17), 1852. https://doi.org/10.3390/diagnostics14171852